Executive record

Sai Rangarao

Chief Commercial Officer at Pelthos Therapeutics Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:sai-rangaraoVersion: public-0As of: 2026-09-29

Not yet claimed6 published Claims2 sources
  • Executive

Key Claims

Biography

Over 8+ decades of experience leading and marketing pharmaceutical products including Otezla. Previously VP of Marketing at Collegium Pharmaceutical and BDSI, Head of Dermatology Marketing at Celgene. Holds MS in Bioscience Regulatory Affairs, MBA, MS, and BS in Computer Science.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. Current · dates not publishedChief Commercial Officer · Pelthos Therapeutics Inc.
  2. 2026 to end not publishedExecutive title: Chief Commercial Officer · Organization not publishedPTHS 10-K executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Open source

    sec def 14a · Source published: Aug 18, 2026 · Retrieved: Sep 12, 2026

    Supports 1 claim
    • Professional Role: Chief Commercial Officer at Pelthos Therapeutics Inc. · Claim reviewed: Sep 12, 2026

  2. PTHS 10-K executive officers

    sec filing · Source published: Mar 19, 2026 · Retrieved: May 16, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Pelthos Therapeutics Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chief Commercial Officer · Claim reviewed: May 16, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: May 16, 2026